Photosensitizing Agents for Phototherapy
- Name
- Photosensitizing Agents for Phototherapy
- Accession Number
- DBCAT005162
- Description
Included in this category are drugs that are used to therapeutic advantage for their photosensitizing ability. This includes agents used in photodynamic and photochemotherapy (PUVA).
- Drugs
Drug Drug Description Aminolevulinic acid A porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma. Methyl aminolevulinate A porphyrin precursor used to treat non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp. Porfimer sodium A hematoporphyrin derivative used to treat esophageal cancer, endobronchial cancer, and high grade dysplasia in Barrett's Esophagus. Methoxsalen A furocoumarin used to treat psoriasis and vitiligo. Bergapten Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis). Trioxsalen A psoralen derivative that has been used in combination with UV light to treat vitiligo, but has been discontinued by its manufacturer. - Drugs & Drug Targets